Carl Zeiss Meditec AG (AFXG)

66.000 0.000 (0.00%)
Close EUR Disclaimer

AFXG Financial Summary

Carl Zeiss Meditec AG reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was EUR 472.13 million compared to EUR 504.22 million a year ago. Net income was EUR 46.48 million compared to EUR 62 million a year ago. Basic earnings per share from continuing operations was EUR 0.52 compared to EUR 0.69 a year ago.For the six months, sales was EUR 947.16 million compared to EUR 974.48 million a year ago. Net income was EUR 83.87 million compared to EUR 113.05 million a year ago. Basic earnings per share from continuing operations was EUR 0.94 compared to EUR 1.26 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
AFXG
Gross margin TTM 56.32%
Operating margin TTM 15.42%
Net Profit margin TTM 12.67%
Return on Investment TTM 10.3%
Total Revenue
Net Income
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Revenue 472.12 475 579.70 535.12
Gross Profit 252.54 252.50 340.26 315.97
Operating Income 64.95 43.80 107.87 101.38
Net Income 46.48 37.40 85.20 92.15
Clear All
0Selected
Please try another search
AFXG
Quick Ratio MRQ 0.72
Current Ratio MRQ 3.51
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 6.78%
Total Assets
Total Liabilities
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Assets 2,920.19 3,032.92
Total Liabilities 812.92 860.02
Total Equity 2,107.27 2,172.90 1,978.07
Clear All
0Selected
Please try another search
AFXG
Cash Flow/Share TTM 2.94
Revenue/Share TTM 23.05
Operating Cash Flow 0.00%
Cash
Net Change in Cash
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
Clear All
0Selected
Please try another search

* In Millions of EUR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles